Inga-Marie Schaefer, MD, is Assistant Professor in Pathology at Harvard Medical School and Associate Pathologist at Brigham and Women’s Hospital. Dr. Schaefer is also an Associate Member of the Broad Institute.
Dr. Schaefer is a Board of Directors member of CTOS, a member of the USCAP/IAP, AACR, SARC, and CTOS, and an editorial board member of Genes, Chromosomes & Cancer.
Dr. Schaefer earned her medical degree (MD) from the Georg-August University in Göttingen, Germany, and the University of Bern, Switzerland. She trained in Anatomic Pathology at the University Hospital Göttingen and at Brigham and Women’s Hospital. During her postdoctoral studies in Dr. Jonathan Fletcher’s laboratory at Brigham and Women’s Hospital, she characterized mechanisms of GIST genomic progression and identified early inactivation of the MAX tumor suppressor as recurrent event in GIST. In 2018, she obtained board certification in Anatomic Pathology and became faculty in the Department of Pathology at Brigham and Women’s Hospital. Dr. Schaefer leads a research program centered on the biology, genetic, and molecular mechanisms of sarcomas with the goal to develop novel therapeutics.
